Purpose This systematic review aimed to investigate the association between VAI and blood
pressure. Methods The study was according to the PRISMA standards and the bibliographic …

Background and Aims. Visceral adiposity index (VAI) is a novel marker of fat distribution and
function which incorporates both anthropometric and laboratory measures. Recently, several …

(1) Background. Visceral adiposity index (VAI) has been recently identified as a new
cardiometabolic risk marker reflecting abdominal fat distribution and dyslipidaemia. The aim …

Background The increasing trend in childhood obesity needs to be closely monitored and
intervened due to long-term health issues such as metabolic syndrome, cardiovascular …

Background Visceral adiposity index (VAI) has been identified as a cardiometabolic risk
marker in children and adolescents which reflects abdominal fat distribution. The aim of the …

Background The fat mass estimators waist-to-height ratio (WHtR) and relative fat mass—
pediatric (RFMp) complement the widely accepted body mass index (BMI) in obesity …

Background: Childhood obesity is one of the major challenges of public health policies. The
problem of fatty liver in childhood, known as MAFLD (metabolic dysfunction-associated fatty …

Background and aims Recently, new indices combining routine and low-cost anthropometric
and biochemical measurements have emerged. Among them, the visceral adiposity index …

Systemic sclerosis (SSc) is an autoimmune disease characterized by systemic inflammation,
endothelial dysfunction, generalized fibrosis and high cardiovascular mortality. The …

Recombinant human growth hormone therapy, which was introduced in the 1980s, is now
routine for children with advanced chronic kidney disease (CKD) who are exhibiting growth …